Reprocell Inc., of Yokohama, Japan, a venture company established by the University of Tokyo and Kyoto University that offers commercial induced pluripotent stem (iPS) cells, acquired Reinnervate Ltd., of County Durham, UK, and Bioserve Biotechnologies Ltd., of Beltsville, Md., to accelerate its iPS cell business by establishing a global distribution network and developing patient-derived iPS cells in areas such as Alzheimer's, Parkinson's and cardiovascular diseases.